The Gross Margin of Heron Therapeutics Inc (HRTX) is 73.21%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 73.21% |
| 2023-12-31 | 48.75% |
| 2022-12-31 | 49.03% |
| 2021-12-31 | 46.70% |
| 2020-12-31 | 59.14% |
| 2019-12-31 | 57.81% |
| 2018-12-31 | 64.52% |
| 2017-12-31 | 85.06% |
| 2016-12-31 | 92.31% |